Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000896264-23-000010
Filing Date
2023-05-09
Accepted
2023-05-09 13:37:32
Documents
56
Period of Report
2023-04-01

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20230401.htm   iXBRL 10-Q 771993
2 EX-31.1 usna-20230401xex311.htm EX-31.1 10117
3 EX-31.2 usna-20230401xex312.htm EX-31.2 9978
4 EX-32.1 usna-20230401xex321.htm EX-32.1 3585
5 EX-32.2 usna-20230401xex322.htm EX-32.2 3981
  Complete submission text file 0000896264-23-000010.txt   3770257

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20230401.xsd EX-101.SCH 26110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT usna-20230401_cal.xml EX-101.CAL 46369
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT usna-20230401_def.xml EX-101.DEF 82029
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20230401_lab.xml EX-101.LAB 343074
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20230401_pre.xml EX-101.PRE 210700
50 EXTRACTED XBRL INSTANCE DOCUMENT usna-20230401_htm.xml XML 544832
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 23901257
SIC: 2833 Medicinal Chemicals & Botanical Products